Integrated BioPharmaINBP 
$0.22-4.35%24h
-4.35%24h
Global rank33865
Market cap$6.59M
Change 7d10.00%
YTD Performance-12.00%
SP500 benchmarkUnderperform
P/E-193.83
P/S0.13
Revenue$50.67M
Earnings-$34.00K
Dividend yield-
Main Sector
Consumer Defensive
Category
Integrated BioPharma (INBP) Total Liabilities
INBP Total Liabilities in 2022: $6.57M
According to Integrated BioPharma latest financial reports the total liabilities of INBP is $6.57M, an decrease of -1.57% to 2022. At the end of 2022 company had $6.67M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Integrated BioPharma is responsible for during its operational activities.
Integrated BioPharma (INBP) Total Liabilities History from 2023 to 2022
-
Value:-
INBP Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $6.57M | -1.57% |
| 2022 | $6.67M | -39.90% |
| 2021 | $11.11M | -34.19% |
| 2020 | $16.88M | 0.76% |
| 2019 | $16.75M | - |
View the Top Total Liabilies Stocks
